NEUTRISCI ARRANGES $1,500,000 PRIVATE PLACEMENT
Vancouver, British Columbia – November 7, 2016 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU) (FRANKFURT: 1N9) announces that it has arranged a non-brokered private placement of units (the “Units”) of the Company at a price of ten cents per Unit for gross proceeds of up to $1,500,000. Each Unit consists of one common share of the Company and one common share purchase warrant, entitling the holder to acquire an additional common share of the Company at a price of $0.18 for a period of eighteen months from the date of issuance.
The Company intends to use the net proceeds of the offering to build inventory and for marketing and advertising programs related to neuenergy®, and for general corporate purposes.
Glen Rehman, President of NeutriSci, stated: “This financing will enable us to execute on the marketing programs we have in place to expand the branding and marketing initiatives of neuenergy, as well as to support the continued increase in sales of neuenergy in our growing retail network.”
The Company may pay a finder’s fee to one or more arms’ length parties who introduce the Company to subscribers, in accordance with the policies of the TSX Venture Exchange. The common shares, warrants and shares underlying the warrants will be subject to a four-month-and-one-day statutory hold period from the date of issuance. Closing of the private placement remains subject to the receipt of all regulatory approvals, including the approval of the TSX Venture Exchange.
Neuenergy® is a revolutionary energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash associated with typical energy products.
To find out more about neuenergy®, please visit www.getneuenergy.com.
On Behalf of the Board of Directors of
NEUTRISCI INTERNATIONAL INC.
NeutriSci International Inc.
Tel: (403) 264-6320
For investor relations inquiries:
Skanderbeg Capital Advisors
O: 604‐687‐7130 x105
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.
About NeutriSci International Inc.: NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci is currently focused on building sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers for neuenergy™, the Company’s natural energy and focus supplement that has at its core, the beneficial effects of blueberries. neuenergy™ contains a unique patented combination of blueberries (pterostilbene) and naturally derived caffeine. neuenergy™ provides sustained energy and focus without sugar, calories, carbs or the jitters typically associated with energy products. For more information, visit: www.neutrisci.com.
Statements in this press release have not been evaluated by the Food and Drug Administration. Products or ingredients are not intended to diagnose, treat, cure or prevent any disease.